Status:
COMPLETED
Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Ifakara Health Research and Development Centre
Conditions:
Malaria
Eligibility:
FEMALE
15+ years
Phase:
PHASE4
Brief Summary
This study is an investigation to compare the efficacy of two different intermittent sulfadoxine/pyrimethamine (SP) treatment regimens and intermittent sulfadoxine/pyrimethamine (SP) + artesunate (SP/...
Eligibility Criteria
Inclusion
- Women 15 years of age or older
- First or second pregnancy between 16 and 36 weeks gestation
Exclusion
- Pregnancy prior to 16 weeks or after 36 weeks gestation
- Third or later pregnancy;
- Report previous allergic reactions to SP, AS, or unknown antimalarials;
- If the distance to their home is too great or too inaccessible for follow-up;
- Child's father refuses the woman's participation
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
1614 Patients enrolled
Trial Details
Trial ID
NCT00164255
Start Date
January 1 2003
End Date
June 1 2009
Last Update
September 11 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kibaoni Health Centre
Ifakara, Kilombero District, Tanzania
2
St Francis Designated District Hospital
Ifakara, Kilombero District, Tanzania